Artesunate is a semisynthetic derivative of artemisinin used to treat malaria. It has also been shown to effective against other parasites such as liver flukes. Artesunate also demonstrates cytotoxic action against cancer cell lines of different tumor types. Artesunate has been shown to inhibit TNF–induced production of proinflammatory cytokines via inhibition of NF-B and PI3 […]
More Information Supplier PageArtesunate is a semisynthetic derivative of artemisinin used to treat malaria. It has also been shown to effective against other parasites such as liver flukes. Artesunate also demonstrates cytotoxic action against cancer cell lines of different tumor types. Artesunate has been shown to inhibit TNF–induced production of proinflammatory cytokines via inhibition of NF-B and PI3 […]
More Information Supplier PageArtesunate is a semisynthetic derivative of artemisinin used to treat malaria. It has also been shown to effective against other parasites such as liver flukes. Artesunate also demonstrates cytotoxic action against cancer cell lines of different tumor types. Artesunate has been shown to inhibit TNF–induced production of proinflammatory cytokines via inhibition of NF-B and PI3 […]
More Information Supplier PageArtesunate is a semisynthetic derivative of artemisinin used to treat malaria. It has also been shown to effective against other parasites such as liver flukes. Artesunate also demonstrates cytotoxic action against cancer cell lines of different tumor types. Artesunate has been shown to inhibit TNF–induced production of proinflammatory cytokines via inhibition of NF-B and PI3 […]
More Information Supplier PageArtemisinin and its derivatives are a group of drugs that possess the most rapid action of all current drugs against Plasmodium falciparum malaria.
More Information Supplier PageArtemisinin and its derivatives are a group of drugs that possess the most rapid action of all current drugs against Plasmodium falciparum malaria.
More Information Supplier PageAS-605240 is an orally active inhibitor of PI3-kinase ?? that inhibits human recombinant PI3K??, ??, ??, and ?? in an ATP-competitive manner with IC50 values of 8, 60, 270, and 300 nM, respectively.
More Information Supplier PageAS703026 is a novel, selective, orally bioavailable MEK1/2 inhibitor that inhibits growth and survival of MM cells and cytokine-induced osteoclast differentiation.
More Information Supplier Page
